Pseudouridine, an isomer of uridine (U), is used as a tumor marker to guide the diagnosis, monitoring and efficacy assessment of malignancies such as lung, breast and liver cancers. Although normal mRNA present in vivo has uridine as one of the four nucleic acid compounds in the sequence, mRNA developed as a therapeutic agent or vaccine is made using a modified nucleic acid (pseudouridine) instead of uridine (and other derivatives). Pseudouridine was originally present in the body as a component, such as tRNA (transfer RNA), which is a type of RNA.
The Pseudouridine industry can be broken down into several segments, Powder, Liquid, etc.
Across the world, the major players cover YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies (Maravai LifeSciences), MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Ulcho Biochemical Ltd (FCAD Group), Wuhan Finetech, etc.
Pseudouridine Market contains market size and forecasts of Pseudouridine in global, including the following market information:
- Global Pseudouridine Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Pseudouridine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Pseudouridine companies in 2021 (%)
The global Pseudouridine market was valued at 91 million in 2021 and is projected to reach US$ 701.9 million by 2028, at a CAGR of 33.9% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pseudouridine include YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene and Ulcho Biochemical Ltd(FCAD Group), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pseudouridine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pseudouridine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pseudouridine Market Segment Percentages, by Type, 2021 (%)
Global Pseudouridine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pseudouridine Market Segment Percentages, by Application, 2021 (%)
- Vaccine
- Scientific Research
Global Pseudouridine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pseudouridine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pseudouridine revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Pseudouridine revenues share in global market, 2021 (%)
- Key companies Pseudouridine sales in global market, 2017-2022 (Estimated), (Kg)
- Key companies Pseudouridine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- YAMASA CORPORATION
- Biosynth Carbosynth
- TriLink BioTechnologies
- MP Biomedicals, Inc
- Thermo Scientific Chemicals
- BOC Sciences
- Toronto Research Chemical
- Wuhan Glycogene
- Ulcho Biochemical Ltd(FCAD Group)
- Wuhan Finetech
- Shanghai Hongene Biotech
Industry Market Size
